BB Good human data, but mixed outcomes or surrogate markers. How we grade →RCT · 1,027 patients aged 70 to 82
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial
A Kalstad, P Myhre, K Laake, S Tveit, E Schmidt, P Smith et al. Circulation. 2021.
- In plain language
- OMEMI: 1.8 g a day of EPA plus DHA for 2 years after a heart attack did not reduce cardiovascular events versus corn oil (21.4% vs 20.0%); new atrial fibrillation was 7.2% vs 4.0%.
- Limits
- Mid-sized and 2 years only; older Norwegian patients; atrial fibrillation finding just missed significance (P = 0.06).
- Which of our grades it feeds
- CC Small or few human trials. Promising, not proven. How we grade →Science summary: Omega-3: triglycerides, heart outcomes and why the big trials differ
- Source
- doi.org/10.1161/CIRCULATIONAHA.120.052209 · PubMed 33191772
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.